http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Wang, James Q.,Jeelall, Yogesh S.,Humburg, Peter,Batchelor, Emma L.,Kaya, Sarp M.,Yoo, Hee Min,Goodnow, Christopher C.,Horikawa, Keisuke The Rockefeller University Press 2017 The Journal of experimental medicine Vol.214 No.9
<P><I>CD79B</I> and <I>MYD88</I> mutations are frequently and simultaneously detected in B cell malignancies. It is not known if these mutations cooperate or how crosstalk occurs. Here we analyze the consequences of <I>CD79B</I> and <I>MYD88<SUP>L265P</SUP></I> mutations individually and combined in normal activated mouse B lymphocytes. <I>CD79B</I> mutations alone increased surface IgM but did not enhance B cell survival, proliferation, or altered NF-κB responsive markers. Conversely, B cells expressing <I>MYD88<SUP>L265P</SUP></I> decreased surface IgM coupled with accumulation of endoglycosidase H–sensitive IgM intracellularly, resembling the trafficking block in anergic B cells repeatedly stimulated by self-antigen. Mutation or overexpression of CD79B counteracted the effect of <I>MYD88<SUP>L265P</SUP></I>. In B cells chronically stimulated by self-antigen, <I>CD79B</I> and <I>MYD88<SUP>L265P</SUP></I> mutations in combination, but not individually, blocked peripheral deletion and triggered differentiation into autoantibody secreting plasmablasts. These results reveal that CD79B and surface IgM constitute a rate-limiting checkpoint against B cell dysregulation by <I>MYD88<SUP>L265P</SUP></I> and provide an explanation for the co-occurrence of <I>MYD88</I> and <I>CD79B</I> mutations in lymphomas.</P>
Identification of Novel Regulators of B Cell Development and Function Using ENU Mutagenesis
Anselm Enders,Mehmet Yabas,Lisa A Miosge,Alanna Short,Yovina Sontani,Hannes Bergmann,Belinda Whilttle,Nadine Bartel,T. Daniel Andrews,Matthew A Field,Yafei Zhang,Edward M Bertram,Christopher C Goodnow 한국실험동물학회 2014 한국실험동물학회 학술발표대회 논문집 Vol.2014 No.8